Q1/808/2026 - Group 4 Medications: Blood

This tender, identified as Q1/808/2026, concerns the procurement of Group 4 medications, specifically those related to blood. The scope of this acquisition likely involves the supply of various blood products, blood derivatives, or medications used in the treatment of blood-related conditions. The tender is issued to ensure the availability of essential medical supplies for healthcare facilities, potentially within a specific region or for a particular healthcare network. Interested suppliers are expected to provide detailed proposals outlining their capacity to meet the specified requirements, including product quality, delivery timelines, and compliance with regulatory standards. The objective is to secure a reliable source of these critical medications to support patient care and public health initiatives. Further details regarding the specific types and quantities of blood-related medications required, as well as the evaluation criteria for bids, would be available in the full tender documentation. This procurement is crucial for maintaining adequate stock levels of vital treatments within the healthcare system.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 367.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.